Skip to content

NeuroSense Therapeutics Ltd.: current assets

Current assets for NeuroSense Therapeutics Ltd. Inspect selected reporting periods, original units and SEC filing links; download the financial history.

All NeuroSense Therapeutics Ltd. financial histories

What this measure means

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Exact concept: us-gaap:AssetsCurrent. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2023-12-31 to 2025-12-31. The SEC response was captured on 2026-09-21.

Selected filing history

Current assets in original reported units, latest-filed observation per period
Period startPeriod endValueUnitFiledSource filing
At date2025-12-31778,000USD2026-03-3120-F · 0001213900-26-036970
At date2024-12-314,402,000USD2026-03-3120-F · 0001213900-26-036970
At date2023-12-312,916,000USD2025-04-0720-F · 0001213900-25-029464

Related financial histories

Inspect the source

Entity
NeuroSense Therapeutics Ltd. / CIK 0001875091
Captured
2026-09-21T17:32:35.374Z
SEC response SHA-256
d40a450753dd9b8b449c134069325b8093fe4c4b999680ec2859a95439fb3ede

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001875091.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))